CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 14 enrolled
Drug / intervention
Latanoprost (Xalatan) +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00187577
NCT00187577N/ACompleted

Efficacy and Safety of Latanoprost (Xalatan) and Bimatoprost (Lumigan) Ophthalmic Solutions in Promoting Eyelash Growth in Patients With Alopecia Areata

University of California, San Francisco·interventional·Posted Sep 16, 2005·Updated Jun 9, 2011

In Brief

A clinical study evaluating Latanoprost (Xalatan), Bimatoprost (Lumigan), and 1 other intervention for Alopecia Areata. Completed, enrolled 14 participants across 1 site.

Detailed Summary

This is a single center, randomized, investigator-masked study to determine the efficacy and safety of latanoprost and bimatoprost ophthalmic solutions in promoting eyelash growth in patients who have lost their eyelashes due to alopecia areata. These medications are FDA-approved as eyedrops for patients with glaucoma who have been noted to grow longer, darker, and thicker eyelashes with their use. In this study, patients will be asked to apply these solutions to the affected eyelid margins of one eye with a sterile cotton-tipped applicator once a day.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAlopecia Areata
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 16, 2005
Enrollment StartJun 1, 2005
Primary CompletionFeb 1, 2006
Study CompletionMar 1, 2006
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 20.8 years ago

Interventions

Latanoprost (Xalatan)drug

Bimatoprost (Lumigan)drug

Bimatoprost solution will be applied to affected eyelid(s) with cotton-tipped applicator daily.

Topical application of latanoprost solution to eyeliddrug

Subject will apply latanoprost to affected eyelid with cotton-tipped applicator daily.